Patent details

Basic Information

Publication number:

EP1463506

PCT Application Number:

PCT/GB/2002/005845

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP027882141

PCT Publication Number:

WO/2003/055491

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES

French Title of Invention:

DERIVES DE LA QUINAZOLINE SUBSTITUES UTILISES EN TANT QU'INHIBITEURS DES KINASES AURORA

German Title of Invention:

SUBSTITUIERTE CHINAZOLIN-DERIVATE ALS AURORA-KINASE INHIBITOREN

SPC Number:

Dates

Filing date:

20/12/2002

Grant date:

21/10/2009

EP Publication Date:

21/10/2009

PCT Publication Date:

10/07/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/10/2004

EP B1 Publication Date:

21/10/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

20/12/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/12/2002

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Agent

Name:

VAN MALDEREN JOELLE

From:

21/01/2010

Address:

ROUTE D'ARLON 261, 8002, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

PASQUET Georges Rene

Address:

France (FR)

2

Name:

JUNG Frederic Henri

Address:

France (FR)

Priority

Priority Number:

01403357

Priority Date:

24/12/2001

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 31/517;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

10/12/2021

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages